z-logo
open-access-imgOpen Access
Iron chelation in sickle cell disease
Author(s) -
Sophia Delicou
Publication year - 2018
Publication title -
hematology and transfusion international journal
Language(s) - Uncategorized
Resource type - Journals
ISSN - 2469-2778
DOI - 10.15406/htij.2018.06.00164
Subject(s) - thalassemia , hemochromatosis , deferiprone , medicine , hereditary spherocytosis , deferasirox , disease , chelation therapy , anemia , myelofibrosis , wiskott–aldrich syndrome , immunology , biology , genetics , bone marrow , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom